首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Synthesis and In-vitro Cytotoxicity Assessment of N-(5-(Benzylthio)-134- thiadiazol-2-yl)-2-(4-(trifluoromethyl)phenyl)acetamide with Potential Anticancer Activity
【2h】

Synthesis and In-vitro Cytotoxicity Assessment of N-(5-(Benzylthio)-134- thiadiazol-2-yl)-2-(4-(trifluoromethyl)phenyl)acetamide with Potential Anticancer Activity

机译:具有潜在抗癌活性的N-(5-(苄硫基)-134-噻二唑-2-基)-2-(4-(三氟甲基)苯基)乙酰胺的合成和体外细胞毒性评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cancer is the second leading cause of death in the world. Despite advances in the diagnosis and treatment, overall survival of patients still remains poor. Hence, there is an urgent need for development of new anticancer agents. Considering promising biological activity of 1,3,4-thiadiazole derivatives, in the present study, synthesis and cytotoxicity assessment of new derivatives of this ring was done. All synthesized compounds were characterized by NMR, IR and MS spectroscopic methods. Obtained data from MTT assay showed that all compounds 3a- 3l had better anticancer activity against MDA(breast cancer) compared to PC3(prostate cancer) and U87(Glioblastoma). Compound 3 g with m-OCH3 moiety on the phenyl ring was the most potent one in this series with IC50 = 9 μM against MDA breast cell line in comparison with imatinib (IC50 = 20 μM) as reference drug.
机译:癌症是世界上第二大死亡原因。尽管诊断和治疗方面取得了进步,但患者的总体存活率仍然很差。因此,迫切需要开发新的抗癌剂。考虑到1,3,4-噻二唑衍生物的有前途的生物活性,在本研究中,对该环的新衍生物进行了合成和细胞毒性评估。所有合成的化合物均通过NMR,IR和MS光谱法表征。从MTT测定法获得的数据表明,与PC3(前列腺癌)和U87(胶质母细胞瘤)相比,所有化合物3a-3l对MDA(乳腺癌)具有更好的抗癌活性。与作为参考药物的伊马替尼(IC50 = 20μM)相比,在苯环上具有m-OCH3部分的化合物3 g是该系列中最有效的化合物,对MDA乳腺癌细胞系的IC50 = 9μM。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号